Valuation (12%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -1.24 | 37.05 |
| PEG Ratio (TTM) | -0.96 | -2.99 |
| P/S Ratio (TTM) | 22.54 | 6.28 |
| P/B Ratio (TTM) | 1.34 | 4.59 |
| P/FCF Ratio (TTM) | -1.53 | 45.67 |
| Price to 5YR AVG Earnings Ratio | N/A | 63.25 |
| Price to 5YR AVG FCF Ratio | N/A | 35.41 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -77.41% | 5.47% |
| ROE (TTM) | -80.08% | 25.57% |
| Net Profit Margin (TTM) | -1,808.93% | 2.92% |
| ROIC 5YR AVG | N/A | 4.71% |
Growth (22%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -1.08% | 304.99% | N/A |
| Revenue | -25.00% | N/A | N/A |
| Net Income | -3.75% | 457.77% | N/A |
| Cash Flow | 4.04% | -99.54% | N/A |
Health (32%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 7.44 | 2.48 |
| Quick Ratio (TTM) | 7.44 | 1.86 |
| D/E Ratio (TTM) | N/A | 0.01 |
| Interest Coverage (TTM) | -3,050.82 | 12.18 |
| Piotroski F-Score | 2 | 6 |
| Altman Z-Score | N/A | 6.91 |
| LTL to 5YR AVG FCF | N/A | 3.65 |
| Shares Outstanding Growth 5YR AVG | N/A | 2.13% |